[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371667-105":59,"doc-detail-371667-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-inner-nuclear-membrane-protein-banf1-has-an-essential-role-in-triple-negative-breast-cancer-cell-proliferation-and-survival","The inner nuclear membrane protein, Banf1, has an essential role in triple negative breast cancer cell proliferation and survival","","Triple negative breast cancers (TNBCs) are aggressive and lack ER/PR and HER2 expression, with limited therapeutic advances and substantial chemotherapy-related off-target toxicity. This study evaluates the TNBC target Barrier-to-Autointegration Factor 1 (Banf1), assessing expression, localisation, and function in non-malignant breast cells and TNBC cell lines. Bioinformatic patient analysis shows Banf1 overexpression across stages and subtypes, while Banf1 depletion inhibits TNBC proliferation, triggers mitotic arrest, disrupts nuclear envelope integrity, and induces TNBC tumour cell-specific death, supporting further anticancer investigation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-inner-nuclear-membrane-protein-banf1-has-an-essential-role-in-triple-negative-breast-cancer-cell-proliferation-and-survival/371667/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-inner-nuclear-membrane-protein-banf1-has-an-essential-role-in-triple-negative-breast-cancer-cell-proliferation-and-survival/371667.png","ImageObject",300,407,{"name":92,"@type":93},"Đào","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main therapeutic target investigated in this study?","Question",{"text":112,"@type":113},"The study focuses on Barrier-to-Autointegration Factor 1 (Banf1) as a novel TNBC target and evaluates its expression, localisation, and functional impact.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does Banf1 depletion affect triple negative breast cancer cells?",{"text":117,"@type":113},"Banf1 depletion inhibits proliferation and induces mitotic arrest in TNBC cells, associated with loss of nuclear envelope integrity and abnormal nuclear morphology.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports Banf1 as overexpressed in breast cancer?",{"text":121,"@type":113},"Bioinformatic analysis of patient samples indicates that Banf1 is overexpressed across all breast cancer stages and subtypes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371667,1790216059,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe inner nuclear membrane protein, Banf1, has an essential role in triple negative breast cancer cell proliferation and survival  \nMaddison Rose1, Joshua T. Burgess1, Chee Man Cheong1, Iain Richard1,2, Amila Suraweera1, Mark N. Adams1,3, Pascal H. G. Duijf4, Kenneth J. O’Byrne1,3,4,5, Derek J. Richard1,3 & Emma Bolderson1,3,6􀀍  \nTriple negative breast cancers (TNBCs) are a heterogenous subcategory of breast cancers which have significantly worse survival outcomes compared to other breast cancer subtypes. However, limited advances have been made towards a targeted TNBC therapeutic and traditional chemotherapies remain the frontline therapy. Therefore, this study aimed to examine the therapeutic potential of a novel TNBC target, Barrier-to-Autointegration Factor 1 (Banf1), including determining Banf1 expression and cellular localisation in non-malignant breast cells and a panel ofTNBC cell lines. Bioinformatic analysis of patient samples demonstrated that Banf1 is overexpressed in all breast cancer stages and subtypes. Banf1 depletion inhibited proliferation and induced mitotic arrest in TNBC cells via loss of nuclear envelope integrity and aberrant nuclear morphology, inducing TNBC tumour cell-specific cell death. These findings highlight the significant overexpression and functional involvement of Banf1 inTNBC progression and suggests that it may have potential as a novel anticancer target, supporting further investigation.  \nKeywords Breast cancer, Nuclear envelope, Banf1, Mitosis  \nTriple negative breast cancer (TNBC) represents a heterogenic subset of breast cancers which do not express theoestrogen (ER) and progesterone (PR) receptors and lack overexpression of the human epidermal growth factor receptor 2 (HER2)1,2. TNBC is an aggressive, highly metastatic breast cancer subtype, which has significantly worse survival outcomes compared with other breast cancer subtypes3–5. For example, the 5-year survival rate of Stage IV TNBC patients was only 10.81%, compared to 33.46% for other breast cancer subtypes6,7. TNBC is generally less responsive to treatments versus non-TNBC tumours. For instance, in patients undergoing surgical and chemotherapeutic treatment modalities, 62.1% of TNBC patients were disease-free at a 5-year follow up, compared to 80.8% in non-TNBC patients8. Given the lack of hormone receptors, chemotherapeutic drugs remain the gold standard treatment modalities for TNBC9. These conventional therapies however, offer limited improvements in patient reported outcomes, whilst inducing substantial off-target, adverse effects which negatively affect the patient’s quality of life during treatment10. These effects are largely attributed to chemotherapies targeting all rapidly dividing cells, and not specifically malignant cells. Consequently, side effects including, nausea, vomiting, myelosuppression, and hair loss are frequently reported by patients undergoing these treatments11, 12. Therefore, there is an evident need for the development of novel, targeted therapeutic approaches for TNBC to improve tumour response outcomes and limit adverse side effects experienced throughout treatment.  \nThe nuclear envelope (NE) is a double membrane which was initially thought to act solely as a physical barrier separating the cytoplasmic and nuclear components of eukaryotic cells13. The NE and its encompassing proteins,  \n1Cancer Genomics Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, Brisbane, Australia. 2Medical Research Council Laboratory of Molecular Biology (MRC LMB), Cambridge Biomedical Campus, Francis Crick Ave, Trumpington, Cambridge CB2 0QH, UK. 3Queensland University of Technology (QUT), Translational Research Institute, Woolloongabba, Brisbane, Australia. 4Centre for Cancer Biology, University of South Australia & SA Pathology, Adelai","cbCaigMucghyOyVg","https://ap.wps.com/l/cbCaigMucghyOyVg","pdf",5383816,13,"English","# Background and rationale\n## Limitations of current TNBC therapies\n## Triple negative breast cancer characteristics\n# Study target: Banf1\n## Banf1 role and known functions\n# Mechanistic findings\n## Nuclear envelope integrity and mitotic control\n## Effects of Banf1 depletion on TNBC cells\n# Implications\n## Potential for targeted anticancer therapy","[{\"question\":\"What is the main therapeutic target investigated in this study?\",\"answer\":\"The study focuses on Barrier-to-Autointegration Factor 1 (Banf1) as a novel TNBC target and evaluates its expression, localisation, and functional impact.\"},{\"question\":\"How does Banf1 depletion affect triple negative breast cancer cells?\",\"answer\":\"Banf1 depletion inhibits proliferation and induces mitotic arrest in TNBC cells, associated with loss of nuclear envelope integrity and abnormal nuclear morphology.\"},{\"question\":\"What evidence supports Banf1 as overexpressed in breast cancer?\",\"answer\":\"Bioinformatic analysis of patient samples indicates that Banf1 is overexpressed across all breast cancer stages and subtypes.\"}]","The inner nuclear membrane protein, Banf1, has an essential role in triple negative breast cancer cell proliferation and survival | PDF",1790192572,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38c933734639f05975f16c18dc717f03.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fca0b1935850babb07d8868cd89bc3bd.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8947672b82068215e6fdbdf751542ce8.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da729f509c783d4f16ea061464fedb3a.webp",980,1287]